Karl L. Insogna, MD

Professor of Medicine (Endocrinology); Director, Yale Bone Center

Clinical Interests

  • Hyperthyroidism
  • Medical Oncology
  • Osteoporosis

Patient Care

Accepts new patients? No
Patient Type: Adult
Referrals: From physicians only

Patient Care Organizations

Cancer Center, Yale

Center for X-Linked Hypophosphatemia, Yale

Internal Medicine: Diabetes Research Center | Endocrinology: Bone Center

Yale Medical Group

Clinical Trials

Conditions Study Title
Efficacy and safety of KRN23, an antibody to FGF23, in patients with TIO or ENS
Odanacatib in Adolescents Treated with Glucocorticoids
Calcitonin to lower FGF23 levels in patients with X-linked hypophosphatemia

Edit this profile